(Q40688483)

22 September 2017

title

WT1-p53 interactions in insulin-like growth factor-I receptor gene regulation (English)

1 reference

22 September 2017

1 reference

3

1 reference

22 September 2017

Gila Idelman

1

1 reference

22 September 2017

Tova Glaser

series ordinal

2

1 reference

22 September 2017

Haim Werner

series ordinal

4

1 reference

22 September 2017

language of work or name

English

0 references

publication date

19 November 2002

1 reference

Journal of Biological Chemistry

22 September 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

22 September 2017

volume

278

1 reference

22 September 2017

issue

5

1 reference

22 September 2017

page(s)

3474-3482

1 reference

Molecular and cellular aspects of the insulin-like growth factor I receptor

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211606200

New concepts in regulation and function of the insulin-like growth factors: implications for understanding normal growth and neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211606200

The insulin-like growth factor-I receptor signaling pathways are important for tumorigenesis and inhibition of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211606200

Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211606200

Oncogenes and the strategy of growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211606200

Increased expression of the insulin-like growth factor I receptor gene, IGF1R, in Wilms tumor is correlated with modulation of IGF1R promoter activity by the WT1 Wilms tumor gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211606200

Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211606200

Alternative splicing and genomic structure of the Wilms tumor gene WT1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211606200

Inhibition of cellular proliferation by the Wilms' tumor suppressor WT1 is associated with suppression of insulin-like growth factor I receptor gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211606200

Wild-type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211606200

The insulin-like growth factor I receptor as a physiologically relevant target of p53 in apoptosis caused by interleukin-3 withdrawal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211606200

Regulation of insulin-like growth factor I receptor gene expression by Sp1: physical and functional interactions of Sp1 at GC boxes and at a CT element

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211606200

p53 regulates insulin-like growth factor-I (IGF-I) receptor expression and IGF-I-induced tyrosine phosphorylation in an osteosarcoma cell line: interaction between p53 and Sp1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211606200

Physical and functional interaction between WT1 and p53 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211606200

The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211606200

Altered expression of the WT1 wilms tumor suppressor gene in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211606200

p53 alteration is a common event in the spontaneous immortalization of primary BALB/c murine embryo fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211606200

Requirement for p53 and p21 to sustain G2 arrest after DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211606200

Viral oncoproteins discriminate between p53 and the p53 homolog p73.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211606200

Tumor suppressor p53 can participate in transcriptional induction of the GADD45 promoter in the absence of direct DNA binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211606200

WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211606200

Wilms' tumour-suppressor protein isoforms have opposite effects on Igf2 expression in primary embryonic cells, independently of p53 genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211606200

Differential effects of Wilms tumor WT1 splice variants on the insulin receptor promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211606200

Aberrant expression of the tumour suppressor gene p53 is very frequent in Wilms' tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211606200

21 January 2018

Identifiers

DOI

10.1074/JBC.M211606200

1 reference

22 September 2017

1 reference